Related Experiment Video
Updated: Aug 10, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Antitumor Functions of Natural Killer Cells and Control of Metastases
1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 15213
Abstract:
Natural killer (NK) cells have been recognized as effector cells responsible for the elimination of blood-borne metastases. Newer evidence suggests that NK cells play an important role in the control of solid tissue metastases. NK cells have the ability to kill a broad variety of fresh or cultured "NK-resistant" tumor cell targets by mechanisms that are not dependent on perforin or granzyme secretion. Also, a subset of interleukin 2 (IL-2)-activated NK cells, which are called A-NK cells, is capable of extravasation, movement in solid tissues, localization to the sites of metastases, and killing tumor cells in situ. Studies in experimental animals and in cancer patients indicate that systemic adoptive immunotherapy with A-NK cells and IL-2 is a tolerable and promising treatment for advanced solid tissue as well as hematologic neoplasms. In this article, antitumor functions of A-NK cells in vitro and in vivo are reviewed, and the mechanisms responsible for their antitumor effects are considered.
Insights
Natural killer (NK) cells, particularly activated NK (A-NK) cells, show promise in eliminating solid tissue metastases. These cells effectively kill tumor cells in situ and are a potential immunotherapy for advanced cancers.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Therapy
Background:
- Natural killer (NK) cells are crucial for eliminating blood-borne metastases.
- Emerging research highlights NK cell importance in controlling solid tissue metastases.
- NK cells can eliminate diverse tumor targets via perforin/granzyme-independent mechanisms.
Purpose of the Study:
- To review the antitumor functions of activated NK (A-NK) cells.
- To explore the mechanisms underlying A-NK cell-mediated antitumor effects.
- To assess the therapeutic potential of A-NK cells in solid tissue and hematologic neoplasms.
Main Methods:
- In vitro studies assessing NK cell cytotoxicity against tumor targets.
- In vivo investigations in experimental animals and cancer patients.
- Analysis of A-NK cell extravasation, tissue migration, and in situ tumor cell killing.
Main Results:
- A subset of interleukin 2 (IL-2)-activated NK cells (A-NK cells) demonstrates enhanced capabilities.
- A-NK cells can extravasate, migrate within solid tissues, and localize to metastatic sites.
- A-NK cells effectively kill tumor cells in situ through novel mechanisms.
Conclusions:
- Systemic adoptive immunotherapy with A-NK cells and IL-2 is a tolerable and promising treatment strategy.
- A-NK cells represent a significant advancement in cancer immunotherapy for advanced solid and hematologic neoplasms.
- Further research into A-NK cell mechanisms can optimize their clinical application.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy

